61 related articles for article (PubMed ID: 30706728)
1. A two-gene methylation signature for the diagnosis of bladder cancer in urine.
Bosschieter J; Nieuwenhuijzen JA; Hentschel A; van Splunter AP; Segerink LI; Vis AN; Wilting SM; Lissenberg-Witte BI; A van Moorselaar RJ; Steenbergen RD
Epigenomics; 2019 Feb; 11(3):337-347. PubMed ID: 30706728
[TBL] [Abstract][Full Text] [Related]
2. Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population.
Zhao Y; Guo S; Sun J; Huang Z; Zhu T; Zhang H; Gu J; He Y; Wang W; Ma K; Wang J; Yu J
PLoS One; 2012; 7(4):e35175. PubMed ID: 22529986
[TBL] [Abstract][Full Text] [Related]
3. A systematic review on mutation markers for bladder cancer diagnosis in urine.
Hentschel AE; van der Toom EE; Vis AN; Ket JCF; Bosschieter J; Heymans MW; van Moorselaar RJA; Steenbergen RDM; Nieuwenhuijzen JA
BJU Int; 2021 Jan; 127(1):12-27. PubMed ID: 32539176
[TBL] [Abstract][Full Text] [Related]
4. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.
van Bemmel D; Lenz P; Liao LM; Baris D; Sternberg LR; Warner A; Johnson A; Jones M; Kida M; Schwenn M; Schned AR; Silverman DT; Rothman N; Moore LE
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1143-8. PubMed ID: 22539607
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis.
Kong T; Qu Y; Zhao T; Niu Z; Lv X; Wang Y; Ding Q; Wei P; Fu J; Wang L; Gao J; Zhou C; Wang S; Jiang J; Zheng J; Wang K; Wu K
J Transl Med; 2024 Mar; 22(1):314. PubMed ID: 38532419
[TBL] [Abstract][Full Text] [Related]
6. Microchip for detection of cell-free DNA in urine to help identify patients with bladder cancer.
Lu SM; Zhang Y; Dong XT; Wang JL; Li Y; Liang LG
BJU Int; 2024 May; 133(5):536-538. PubMed ID: 38288885
[No Abstract] [Full Text] [Related]
7. EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with Hematuria.
Bang BR; Zhong J; Oh TJ; Lee JY; Seo Y; Woo MA; Lim JS; Na YG; Song KH; Shin JH; Lee JJ; Im CS; Kim S; Beqaj S; Shirk JD; Ke KW; Vallone J; An S
J Mol Diagn; 2024 Apr; ():. PubMed ID: 38677548
[TBL] [Abstract][Full Text] [Related]
8. The Evolution of Polyclonal Antibody from Specific Epitope 47kDA for Detection of Bladder Cancer.
Budaya TN; Permatasari HK; Widodo N; Prawiro SR
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3155-3164. PubMed ID: 37774067
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential.
Bryzgunova OE; Laktionov PP
Acta Naturae; 2015; 7(3):48-54. PubMed ID: 26483959
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers.
Hentschel AE; Nieuwenhuijzen JA; Bosschieter J; Splunter APV; Lissenberg-Witte BI; Voorn JPV; Segerink LI; Moorselaar RJAV; Steenbergen RDM
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32252299
[TBL] [Abstract][Full Text] [Related]
11. The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion.
Hentschel AE; van den Helder R; van Trommel NE; van Splunter AP; van Boerdonk RAA; van Gent MDJM; Nieuwenhuijzen JA; Steenbergen RDM
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33572525
[TBL] [Abstract][Full Text] [Related]
12. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Hermanns T; Savio AJ; Olkhov-Mitsel E; Mari A; Wettstein MS; Saba K; Bhindi B; Kuk C; Poyet C; Wild PJ; Noon A; Bashir S; Juvet T; Rendon RA; Waltregny D; van der Kwast T; Finelli A; Kulkarni GS; Fleshner NE; Lo K; Bapat B; Zlotta AR
Urol Oncol; 2020 Jun; 38(6):603.e1-603.e7. PubMed ID: 32081560
[TBL] [Abstract][Full Text] [Related]
13. The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence.
Mancini M; Righetto M; Zumerle S; Montopoli M; Zattoni F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911596
[TBL] [Abstract][Full Text] [Related]
14. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.
Chen X; Zhang J; Ruan W; Huang M; Wang C; Wang H; Jiang Z; Wang S; Liu Z; Liu C; Tan W; Yang J; Chen J; Chen Z; Li X; Zhang X; Xu P; Chen L; Xie R; Zhou Q; Xu S; Irwin DL; Fan JB; Huang J; Lin T
J Clin Invest; 2020 Dec; 130(12):6278-6289. PubMed ID: 32817589
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
Cheng THT; Jiang P; Teoh JYC; Heung MMS; Tam JCW; Sun X; Lee WS; Ni M; Chan RCK; Ng CF; Chan KCA; Chiu RWK; Lo YMD
Clin Chem; 2019 Jul; 65(7):927-936. PubMed ID: 30988170
[TBL] [Abstract][Full Text] [Related]
16. Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
Markus H; Zhao J; Contente-Cuomo T; Stephens MD; Raupach E; Odenheimer-Bergman A; Connor S; McDonald BR; Moore B; Hutchins E; McGilvrey M; de la Maza MC; Van Keuren-Jensen K; Pirrotte P; Goel A; Becerra C; Von Hoff DD; Celinski SA; Hingorani P; Murtaza M
Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597261
[TBL] [Abstract][Full Text] [Related]
17. Detection of colorectal cancer in urine using DNA methylation analysis.
Bach S; Paulis I; Sluiter NR; Tibbesma M; Martin I; van de Wiel MA; Tuynman JB; Bahce I; Kazemier G; Steenbergen RDM
Sci Rep; 2021 Jan; 11(1):2363. PubMed ID: 33504902
[TBL] [Abstract][Full Text] [Related]
18. High Detection Rate for Non-Muscle-Invasive Bladder Cancer Using an Approved DNA Methylation Signature Test.
Steinbach D; Kaufmann M; Hippe J; Gajda M; Grimm MO
Clin Genitourin Cancer; 2020 Jun; 18(3):210-221. PubMed ID: 32139301
[TBL] [Abstract][Full Text] [Related]
19.
Rose M; Bringezu S; Godfrey L; Fiedler D; Gaisa NT; Koch M; Bach C; Füssel S; Herr A; Hübner D; Ellinger J; Pfister D; Knüchel R; Wirth MP; Böhme M; Dahl E
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046186
[TBL] [Abstract][Full Text] [Related]
20. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
